EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy

Jing Wei, Zhi-Ying Jiang, Ling-Feng Ye, Hong-Xiang Lu iD

Immunity, Inflammation and Disease · 2026-03 · 14 (3)

DOI: 10.1002/iid3.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 07.03.2026. Verfasst von Jing Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Ferroptosis, Mast Cells, Sepsis, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Topics on the Development of Medical Science and Technology in Nanjing, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Septic cardiomyopathy (SCM) is a common and life‐threatening complication of severe sepsis, with high mortality due to unclear underlying mechanisms. CXCL4, a key pro‐inflammatory factor, is implicated in various heart diseases, while ferroptosis (iron and lipid hydrogen peroxide‐dependent regulated cell death) plays a crucial role in SCM progression. However, the specific crosstalk between CXCL4, ferroptosis, and SCM remains unelucidated.

Methods

BALB/c mice were randomly divided into six groups (Control, LPS, LPS + Sodium Cromoglycate (CS), LPS + Ferrostatin‐1 (Fer‐1), LPS + Pifithrin‐α (PFT‐α), LPS + Niclosamide) to establish the SCM model via intraperitoneal LPS injection. In vivo experiments included histopathological examination (H&E, toluidine blue staining), survival analysis, ELISA, Western blot, immunofluorescence, immunohistochemistry, TUNEL staining, and detection of myocardial markers (CK‐MB, AST, LDH) and oxidative stress indicators (SOD, MDA, iron content). In vitro, RAW264.7 macrophages were treated with CXCL4 alone or combined with inhibitors (Fer‐1, PFT‐α, Niclosamide), followed by CCK‐8 assay, ROS detection, qRT‐PCR, Western blot, and phagocytosis microbead assay.

Results

In vivo, SCM mice exhibited significantly elevated CXCL4 levels in serum and heart tissue, accompanied by mast cell activation and degranulation. Inhibiting mast cell activation (with CS) reduced CXCL4 production, alleviated cardiac inflammation and ferroptosis (increased SLC7A11/GPX4 expression, decreased 4‐HNE), and improved survival. TUNEL staining revealed predominant macrophage death in SCM hearts. In vitro, CXCL4 induced macrophage ferroptosis (downregulated SLC7A11/GPX4) and impaired phagocytic function (reduced CD36/MERTK expression), which was reversed by Fer‐1. Mechanistically, CXCL4 activated STAT3 phosphorylation, regulating downstream P53; inhibiting STAT3 (Niclosamide) or P53 (PFT‐α) alleviated macrophage ferroptosis, restored phagocytosis, and mitigated cardiac injury in SCM mice.

Conclusion

Mast cell‐derived CXCL4 induces macrophage ferroptosis via the STAT3/P53 signaling pathway, impairs macrophage phagocytic function, and exacerbates myocardial injury in SCM. Targeting mast cell activation, CXCL4 release, or the STAT3/P53‐ferroptosis axis may serve as promising therapeutic strategies for SCM. Clinical trial number: Not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMast CellsSepsisCardiomyopathiesPlatelet Factor 4MyocardiumAnimalsMiceMice, Inbred BALB CDisease Models, AnimalRAW 264.7 CellsMaleLipopolysaccharidesOxidative Stress

Stichwörter der Autor:innen

CXCL4SCMferroptosismacrophagemast cell

Substanzen

Platelet Factor 4Lipopolysaccharides

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjng Medical University, Nanjing, China.

ORCID-Profile: Hong-Xiang Lu

Förderung

  • General Research Topics on the Development of Medical Science and Technology in Nanjing
  • National Natural Science Foundation of China

Zitieren

APA

Wei, J., Jiang, Z. Y., Ye, L. F., & Lu, H. X. (2026). Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70359

Vancouver

Wei J, Jiang ZY, Ye LF, Lu HX. Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70359

BibTeX
@article{Wei2026,
  author = {Wei, Jing and Jiang, Zhi-Ying and Ye, Ling-Feng and Lu, Hong-Xiang},
  title = {Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/iid3.70359}
}
Kostenlos starten →